Publications by authors named "Kerstin Westermark"

Claim this Profile
R
Remarkable developments in our performance.
Arne Andersson, Joey Lau Börjesson, Kerstin Westermark

Ups J Med Sci· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining orphan conditions in the context of the European orphan regulation: challenges and evolution.
Daniel J O'Connor, Maria E Sheean, Matthias P Hofer, Stelios Tsigkos, Segundo Mariz, Kerstin Westermark

Nat Rev Drug Discov· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demonstrating significant benefit of orphan medicines: analysis of 15 years of experience in Europe.
Laura Fregonese, Lesley Greene, Matthias Hofer, Armando Magrelli, Frauke Naumann-Winter, Kerstin Westermark

Drug Discov Today· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worldwide collaboration for orphan drug designation.
Segundo Mariz, James H Reese, Kerstin Westermark, Lesley Greene, Takahiro Goto

Nat Rev Drug Discov· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Establishing medical plausibility in the context of orphan medicines designation in the European Union.
Stelios Tsigkos, Segundo Mariz, Jordi Llinares, Laura Fregonese, Stiina Aarum, Kerstin Westermark

Orphanet J Rare Dis· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing medical plausibility in the context of orphan medicines designation in the European Union.
Stelios Tsigkos, Segundo Mariz, Jordi Llinares, Laura Fregonese, Stiina Aarum, Kerstin Westermark

Orphanet J Rare Dis· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of biomarkers in the context of orphan medicines designation in the European Union.
Stelios Tsigkos, Jordi Llinares, Segundo Mariz, Stiina Aarum, Laura Fregonese, Kerstin Westermark

Orphanet J Rare Dis· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Animal models for metabolic, neuromuscular and ophthalmological rare diseases.
Guillaume Vaquer, Frida Rivière, Maria Mavris, Fabrizia Bignami, Jordi Llinares-Garcia, Kerstin Westermark

Nat Rev Drug Discov· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promoting the development of drugs against rare diseases: what more should be done?
Kerstin Westermark, Jordi Llinares

Expert Rev Pharmacoecon Outcomes Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European regulation on orphan medicinal products: 10 years of experience and future perspectives.

Nat Rev Drug Discov· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orphan drugs. EU regulations.
Segundo Mariz, Jordi Llinares, Kerstin Westermark

BMJ· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychopathology and personality traits in patients with treated Wilson disease grouped according to gene mutations.
Kamilla Portala, Erik Waldenström, Lars von Knorring, Kerstin Westermark

Ups J Med Sci· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep in patients with treated Wilson's disease. A questionnaire study.
Kamilla Portala, Kerstin Westermark, Lisa Ekselius, Jan-Erik Broman

Nord J Psychiatry· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collagen type I expression in experimental anaplastic thyroid carcinoma: regulation and relevance for tumorigenicity.
Thèrése Dahlman, Ellen Lammerts, Daniel Bergström, Asa Franzén, Kerstin Westermark

Int J Cancer· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis